| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.23 | 0.4 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |